HealthPhoto: Hindu HealthRevised MRPs of 1,364 Anti-Cancer Drugs Effective, Saving ₹3,540 Crore Annually
From November 9, 2026, revised Maximum Retail Prices (MRPs) for 1,364 anti-cancer formulations have come into effect in India. This price revision is expected to save consumers approximately ₹3,540.38 crore annually. The National Pharmaceutical Pricing Authority (NPPA) capped trade margins on 137 non-scheduled anti-cancer drugs to help reduce treatment costs, though experts call for broader structural reforms to benefit patients.
Hindu Health··New Delhi



